发表于 2025-3-25 04:03:04

Submitted on: 13 October 2020.
Revised on: 01 December 2020.
Accepted on: 27 December 2020.

___________________HEMATOLOGICAL ONCOLOGY---WILEY

AROMA 发表于 2025-3-25 07:54:42

Submitted on: 29 September 2021.
Revised on: 01 January 2022.
Accepted on: 17 February 2022.

___________________HEMATOLOGICAL ONCOLOGY---WILEY

adulterant 发表于 2025-3-25 15:40:20

http://reply.papertrans.cn/2/113/11205/11205-23.png

发表于 2025-3-25 16:19:31

http://reply.papertrans.cn/2/113/11205/11205-24.png

AV-node 发表于 2025-3-25 23:30:38

http://reply.papertrans.cn/2/113/11205/11205-25.png

headway 发表于 2025-3-26 00:16:29

http://reply.papertrans.cn/2/113/11205/11205-26.png

僵硬 发表于 2025-3-26 05:12:57

Submitted on: 17 January 1998.
Revised on: 07 April 1998.
Accepted on: 19 May 1998.

___________________HEMATOLOGICAL ONCOLOGY---WILEY

Infusion 发表于 2025-3-26 11:52:00

Submitted on: 28 April 1998.
Revised on: 24 June 1998.
Accepted on: 28 July 1998.

___________________HEMATOLOGICAL ONCOLOGY---WILEY

果仁 发表于 2025-3-26 15:39:39

http://reply.papertrans.cn/2/113/11205/11205-29.png

sorbitol 发表于 2025-3-26 18:37:24

Submitted on: 24 June 2000.
Revised on: 26 August 2000.
Accepted on: 12 September 2000.

___________________HEMATOLOGICAL ONCOLOGY---WILEY
页: 1 2 [3] 4
查看完整版本: SCIE期刊HEMATOLOGICAL ONCOLOGY 2024/2025影响因子:3.393 (HEMATOL ONCOL) (0278-0232). (HEMATOLOGY)(血液学)Science Citation Index E